DLF, Sun Pharma, ITC Lead Heavy Q1 FY27 Results Day
Dozens of major Indian companies including DLF, Sun Pharma, ITC, Bajaj Finserv, Persistent Systems, and Muthoot Finance report Q1 FY27 earnings on August 3, 2026.
Tag
sun-pharma
IOC Posts Net Loss, NALCO Profit Up 16% in Q1
Indian Oil Corporation swung to a net loss in Q1 FY27 while NALCO reported a 16% rise in profit for the June quarter. The contrasting results open a broad earnings season that includes Maruti Suzuki, Sun Pharma, ITC, and over 100 other companies.
Maruti, Bajaj Finance, Sun Pharma Q1 Results Today
More than 20 major Indian companies including Maruti Suzuki, Sun Pharma, Bajaj Finserv, ITC, and Bajaj Finance report April-June 2026 quarter results on July 31. The results span autos, financials, pharma, energy, and logistics, offering a broad read on domestic demand and earnings momentum.
Sun Pharma Acquires Organon in $11.75 Billion Deal
Sun Pharmaceutical Industries has agreed to acquire Organon & Co in an all-cash deal worth about $11.75 billion, including debt, at $14.00 per share. The deal gives Sun Pharma full ownership of Organon's women's health, biosimilars, and established medicines businesses. This is one of the largest foreign acquisitions
Sun Pharma to Acquire Organon in $11.75 Billion Deal
Sun Pharmaceutical Industries has announced a $11.75 billion acquisition of Organon & Co., a major US pharma firm with a presence in over 140 countries. The deal significantly expands Sun Pharma's women's health and biosimilars portfolio. Financing terms and regulatory clearances across multiple markets are the key
Sun Pharma Buys Organon in $11.75 Billion Deal
Sun Pharma has agreed to buy U.S. healthcare firm Organon in an $11.75 billion deal. Organon, a Merck spinoff from 2021, operates in women's health, biosimilars, and branded medicines. The deal would be Sun Pharma's biggest acquisition to date.
Sun Pharma Buys Organon in $11.75 Billion Deal
Sun Pharma has agreed to acquire Organon & Co. for $11.75 billion in an all-cash deal, one of India's largest pharma acquisitions. The merger pushes Sun Pharma into the global top 25 by revenue and establishes it as a top-10 biosimilar player. The deal is expected to close in early 2027, pending regulatory and
Sun Pharma Buys U.S. Organon in $11.75 Billion Deal
Sun Pharmaceutical Industries has agreed to acquire U.S.-based Organon & Co in an all-cash deal worth $11.75 billion. The deal would be one of the largest overseas acquisitions by an Indian pharma company and expands Sun Pharma's presence in women's health, biosimilars, and branded medicines.
Sun Pharma to Acquire Organon in $12.5 Billion Deal
Sun Pharma is set to acquire US drugmaker Organon for $12.5 billion, paying $4.5 billion in equity and assuming $8.5 billion in debt. The deal, Sun's largest ever, beats out a rival EQT-Gruenthal consortium bid. An official announcement is expected Sunday night or by Monday.
← Back
Tag
sun-pharma
Q1 Results Today Live: DLF, UPL, Torrent Power, IREDA, KEI, Escorts Kubota, Jindal Stainless, Ather, Inox, Nazara, KIMS, MobiKwik, Texmaco, DOMS Q1 results today, Bajaj Finserv, Sun Pharma, ITC, Urban Company, Muthoot Finance, Persistent Systems in focus
Dozens of major Indian companies including DLF, Sun Pharma, ITC, Bajaj Finserv, Persistent Systems, and Muthoot Finance report Q1 FY27 earnings on August 3, 2026.
25d ago · 3 min · Markets
Q1 Results Updates: Indian Oil Corp. Swings To Net Loss, NALCO Profit Rises 16%
Indian Oil Corporation swung to a net loss in Q1 FY27 while NALCO reported a 16% rise in profit for the June quarter. The contrasting results open a broad earnings season that includes Maruti Suzuki, Sun Pharma, ITC, and over 100 other companies.
26d ago · 3 min · Markets
Q1 Results Today Live: Maruti Suzuki, Sun Pharma, Bajaj Finserv, ITC, IOC, Dixon, Bajaj Holdings, ABB India, Kirloskar Brothers, BlueDart, Glenmark, Aether to announce Q1 results, Bajaj Finance, M&M, Vedanta, Tata Steel, Swiggy, Gillette, ICRA, IRFC, Apollo Pipes, Vedanta Aluminium in focus
More than 20 major Indian companies including Maruti Suzuki, Sun Pharma, Bajaj Finserv, ITC, and Bajaj Finance report April-June 2026 quarter results on July 31. The results span autos, financials, pharma, energy, and logistics, offering a broad read on domestic demand and earnings momentum.
28d ago · 4 min · Markets
Sun Pharma to buy Organon in $11.75 billion all-cash deal
Sun Pharmaceutical Industries has agreed to acquire Organon & Co in an all-cash deal worth about $11.75 billion, including debt, at $14.00 per share. The deal gives Sun Pharma full ownership of Organon's women's health, biosimilars, and established medicines businesses. This is one of the largest foreign acquisitions
4mo ago · 1 min · Business
Sun Pharma shares in focus after firm announces $12-billion Organon acquisition
Sun Pharmaceutical Industries has announced a $11.75 billion acquisition of Organon & Co., a major US pharma firm with a presence in over 140 countries. The deal significantly expands Sun Pharma's women's health and biosimilars portfolio. Financing terms and regulatory clearances across multiple markets are the key
4mo ago · 1 min · Business
Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal
Sun Pharma has agreed to buy U.S. healthcare firm Organon in an $11.75 billion deal. Organon, a Merck spinoff from 2021, operates in women's health, biosimilars, and branded medicines. The deal would be Sun Pharma's biggest acquisition to date.
4mo ago · 1 min · Business
Sun Pharma Seals Rs 97,500 Crore Organon Acquisition Deal
Sun Pharma has agreed to acquire Organon & Co. for $11.75 billion in an all-cash deal, one of India's largest pharma acquisitions. The merger pushes Sun Pharma into the global top 25 by revenue and establishes it as a top-10 biosimilar player. The deal is expected to close in early 2027, pending regulatory and
4mo ago · 1 min · Business
Indian drugmaker Sun Pharma to buy U.S. firm Organon in $11.75 billion deal
Sun Pharmaceutical Industries has agreed to acquire U.S.-based Organon & Co in an all-cash deal worth $11.75 billion. The deal would be one of the largest overseas acquisitions by an Indian pharma company and expands Sun Pharma's presence in women's health, biosimilars, and branded medicines.
4mo ago · 1 min · Business
ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till date
Sun Pharma is set to acquire US drugmaker Organon for $12.5 billion, paying $4.5 billion in equity and assuming $8.5 billion in debt. The deal, Sun's largest ever, beats out a rival EQT-Gruenthal consortium bid. An official announcement is expected Sunday night or by Monday.
4mo ago · 1 min · Business
— End of feed —